Call Options Transactions Made in Q1 2023 in Bio Xcel Therapeutics, Inc. (BTAI)
This table provides information about the institutional ownership of Bio Xcel Therapeutics, Inc. (BTAI) during Q1 2023. The information is specifically focused on institutions that hold call options of BioXcel Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
71.2KNew |
$1.26M - $2.37M
|
71.2K
$32K
|
|
|
May 16, 2023
Q1 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
69K+ 191.14% |
$1.22M - $2.29M
|
105K
$47.3K
|
|
|
May 15, 2023
Q1 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
30KNew |
$531K - $997K
|
30K
$13.5K
|
|
|
May 15, 2023
Q1 2023
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
CALL |
14.9KNew |
$264K - $495K
|
14.9K
$6.71K
|
|
|
May 01, 2023
Q1 2023
|
Cutler Group LP
|
SELL
|
CALL |
-800- 80.0% |
$14.2K - $26.6K
|
200
$90
|
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-52.4K- 55.92% |
$927K - $1.74M
|
41.3K
$18.6K
|